Compare Nexome Cap. Mkt. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -9.36%
- PAT(Q) At Rs -1.00 cr has Fallen at -241.3% (vs previous 4Q average)
- NET SALES(Latest six months) At Rs 9.44 cr has Grown at -31.20%
- PBDIT(Q) Lowest at Rs -1.09 cr.
With ROE of 1.8, it has a Very Expensive valuation with a 0.7 Price to Book Value
Stock DNA
Non Banking Financial Company (NBFC)
INR 107 Cr (Micro Cap)
71.00
22
0.00%
0.04
1.82%
0.69
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-12-2018
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Nexome Capital Markets Ltd?
The next results date for Nexome Capital Markets Ltd is scheduled for 11 May 2026....
Read full news article
Nexome Capital Markets Ltd is Rated Strong Sell
Nexome Capital Markets Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Jan 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 02 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Nexome Capital Markets Ltd is Rated Strong Sell
Nexome Capital Markets Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Jan 2026, reflecting a shift from the previous 'Sell' grade. However, all fundamentals, returns, and financial metrics discussed here are current as of 21 April 2026, providing investors with an up-to-date assessment of the stock's position.
Read full news article Announcements 
Intimation Of Obtaning Listing Approval For 1920000 Equity Shares
07-May-2026 | Source : BSEIntimation of obtaning Listing Approval for 1920000 equity shares of Rs. 10/- each issued at a premium of Rs. 54/- each on a preferential basis pursuant to conversion of equity convertible warrants
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026.
05-May-2026 | Source : BSENexome Capital Markets Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 inter alia to consider and approve 1. The Audited Financial Results for the quarter and year ended March 31 2026 in pursuance of Regulation 33 of the (Listing Obligations and Disclosure Requirements) Regulations 2015; 2. Any other matter if required with the permission of the chair.
Disclosure As Per Regulation 29(2) Of SEBI (SAST) Regulations 2011
21-Apr-2026 | Source : BSEDisclosure as per Regulation 29(2) of SEBI (SAST) Regulations 2011 by Mr. Utsav Parekh
Corporate Actions 
11 May 2026
Nexome Capital Markets Ltd has declared 10% dividend, ex-date: 12 Sep 18
No Splits history available
No Bonus history available
Nexome Capital Markets Ltd has announced 1:2 rights issue, ex-date: 05 Mar 26
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Progressive Star Finance Private Limited (20.88%)
Merlin Resources Private Ltd. (6.38%)
20.22%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -86.54% vs -50.18% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -200.00% vs -21.26% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 12.91% vs 47.44% in Sep 2024
Growth in half year ended Sep 2025 is 272.13% vs 221.05% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -11.51% vs -86.99% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 47.67% vs -50.86% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -83.17% vs 341.70% in Mar 2024
YoY Growth in year ended Mar 2025 is -51.45% vs 372.55% in Mar 2024






